TSEM vs. VRNA

Last updated Jun 24, 2026

TSEM (Tower Semiconductor Ltd) and VRNA (Verona Pharma plc) are both stocks. TSEM operates in Semiconductors (Technology), while VRNA operates in Biotechnology (Healthcare). At a 0.13 correlation, their price movements are largely independent.

Performance

TSEM vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tower Semiconductor Ltd (TSEM) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

TSEM

• 1D: -10.79%
• 1M: -0.28%
• YTD: 140.72%
• 6M: 133.42%
• 1Y: 604.69%
• 3Y*: 94.28%
• 5Y*: 57.62%
• 10Y*: 37.14%

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TSEM vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TSEM Tower Semiconductor Ltd	140.72%	127.96%	68.77%	-29.35%	8.87%	53.68%	7.32%	63.23%	-56.75%	55.55%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%

Correlation

The correlation between TSEM and VRNA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.13

Fundamentals

Market Cap TSEM : $32.32B VRNA : $9.72B
EPS TSEM : $2.15 VRNA : -$0.69
PS Ratio TSEM : 19.85 VRNA : 57.97
PB Ratio TSEM : 10.87 VRNA : 34.92
Total Revenue (TTM) TSEM : $1.62B VRNA : $167.65M
Gross Profit (TTM) TSEM : $401.63M VRNA : $159.52M
EBITDA (TTM) TSEM : $571.93M VRNA : -$40.86M

Return for Risk

TSEM vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TSEM

TSEM Risk / Return Rank: 99
TSEM Sharpe Ratio Rank: 100
TSEM Sortino Ratio Rank: 99
TSEM Omega Ratio Rank: 98
TSEM Calmar Ratio Rank: 100
TSEM Martin Ratio Rank: 100

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TSEM vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tower Semiconductor Ltd (TSEM) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TSEM	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	8.60	—	—
Sortino ratio: Return per unit of downside risk	5.74	—	—
Omega ratio: Gain probability vs. loss probability	1.75	—	—
Calmar ratio: Return relative to maximum drawdown	24.37	—	—
Martin ratio: Return relative to average drawdown	84.04	—	—

Drawdowns

Drawdown Indicators

	TSEM	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-99.75%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-25.04%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-45.83%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-55.39%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-62.28%	—	—
Current Drawdown Current decline from peak	-52.75%	—	—
Average Drawdown Average peak-to-trough decline	-85.36%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	7.25%	—	—

Volatility

Volatility by Period

	TSEM	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.44%	—	—
Volatility (6M) Calculated over the trailing 6-month period	58.34%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	70.93%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	48.12%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.06%	—	—

Dividends

TSEM vs. VRNA - Dividend Comparison

Neither TSEM nor VRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

TSEM vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Tower Semiconductor Ltd and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

TSEM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tower Semiconductor Ltd reported a gross profit of 110.95M and revenue of 413.63M. Therefore, the gross margin over that period was 26.8%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

TSEM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tower Semiconductor Ltd reported an operating income of 64.57M and revenue of 413.63M, resulting in an operating margin of 15.6%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

TSEM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tower Semiconductor Ltd reported a net income of 65.03M and revenue of 413.63M, resulting in a net margin of 15.7%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

Frequently Asked Questions

Can I hold both TSEM and VRNA in my portfolio?

TSEM and VRNA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.